Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide

Open access

Abstract

Obesity and related conditions are associated with distressing food preoccupation that often culminates in dysregulated eating behaviors. Incretin-based therapies can reduce excessive weight in obesity, but their impact on dysregulated eating behaviors remains largely unexamined. Understanding how these pharmacologics engage the brain's mesolimbic circuitry may inform the expansion of their therapeutic potential. We report a rare, first-in-human exploration of the physiological action of these therapies by examining the electrophysiology directly within the human nucleus accumbens. After a short-term course of tirzepatide, the patient-participant exhibited increased severe food preoccupation episodes, which were preceded by an increased delta-theta frequency (≤7 Hz) power in the nucleus accumbens region. We propose that the effects of an incretin-based therapy (tirzepatide) on food preoccupation may be associated with modulation of aberrant activity within this key hub of human mesolimbic circuitry.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-025-04035-5

Cites

Statistics

Figures

Fig. 1 Background information of participant 3 and association of increased delta–theta power in the ventral NAc with severe food preoccupation in participants 1 and 2. a, Two quadripolar depth electrodes were placed bilaterally in the ventral NAc of participant 3 with a neurostimulator fully implanted subgaleally in the skull. b, Anatomical figure of participant 3 (view from posterior to anterior): three-dimensional rendering of DBS electrodes and their position in basal forebrain structures in the participant’s native space: ventral NAc, magenta; dorsal NAc, white; putamen, green; caudate, blue; anterior limb of internal capsule (ALIC), light pink. c, Anatomical magnetic resonance imaging of participant 3 (Supplementary Fig. 1). L, left hemisphere; R, right hemisphere. Prior participants in this ongoing trial had similar electrode placement21. d, Timeline of crucial events for participant 3. A larger illustration and specifics for data collection and use are described in the Methods and Supplementary Fig. 2. e, Participant 1 (left ventral NAc): power spectrum (mean ± s.e.m.) during the biomarker discovery (left) and stimulation (right) phases when the participant was relaxing (control, blue) or in a severe food preoccupation state (pink). The bottom black lines indicate frequencies with statistically significant differences in power values between the control and severe food preoccupation conditions after two-sided permutation testing (P < 0.05) with cluster correction. f, Data from participant 2 (left ventral NAc), using the same format as in e. g, Participant 1 (left ventral NAc): delta–theta band (≤7 Hz) power during the biomarker discovery (left) and stimulation (right) phases when the participant was relaxing (control, blue) or in a severe food preoccupation state (pink). The center line of the box indicates the median; the bottom and top edges of the box indicate the 25th and 75th percentiles, respectively. The individual points outside the whiskers are considered as outliers. The top black line with a single asterisk in the box plot shows statistically significant differences between two conditions after two-sided permutation testing (*P < 0.05). h, Data from participant 2 (left ventral NAc), using the same format as in g. For more information, including the right NAc, see Supplementary Fig. 3 and Supplementary Tables 1 and 2. Illustrations in a and d created using BioRender.com.
Fig. 1 Background information of participant 3 and association of increased delta–theta power in the ventral NAc with severe food preoccupation in participants 1 and 2. a, Two quadripolar depth electrodes were placed bilaterally in the ventral NAc of participant 3 with a neurostimulator fully implanted subgaleally in the skull. b, Anatomical figure of participant 3 (view from posterior to anterior): three-dimensional rendering of DBS electrodes and their position in basal forebrain structures in the participant’s native space: ventral NAc, magenta; dorsal NAc, white; putamen, green; caudate, blue; anterior limb of internal capsule (ALIC), light pink. c, Anatomical magnetic resonance imaging of participant 3 (Supplementary Fig. 1). L, left hemisphere; R, right hemisphere. Prior participants in this ongoing trial had similar electrode placement21. d, Timeline of crucial events for participant 3. A larger illustration and specifics for data collection and use are described in the Methods and Supplementary Fig. 2. e, Participant 1 (left ventral NAc): power spectrum (mean ± s.e.m.) during the biomarker discovery (left) and stimulation (right) phases when the participant was relaxing (control, blue) or in a severe food preoccupation state (pink). The bottom black lines indicate frequencies with statistically significant differences in power values between the control and severe food preoccupation conditions after two-sided permutation testing (P < 0.05) with cluster correction. f, Data from participant 2 (left ventral NAc), using the same format as in e. g, Participant 1 (left ventral NAc): delta–theta band (≤7 Hz) power during the biomarker discovery (left) and stimulation (right) phases when the participant was relaxing (control, blue) or in a severe food preoccupation state (pink). The center line of the box indicates the median; the bottom and top edges of the box indicate the 25th and 75th percentiles, respectively. The individual points outside the whiskers are considered as outliers. The top black line with a single asterisk in the box plot shows statistically significant differences between two conditions after two-sided permutation testing (*P < 0.05). h, Data from participant 2 (left ventral NAc), using the same format as in g. For more information, including the right NAc, see Supplementary Fig. 3 and Supplementary Tables 1 and 2. Illustrations in a and d created using BioRender.com.CC BY-NC-ND · PubMed Central
Fig. 2 Association of increased delta–theta power in the ventral NAc with severe food preoccupation in participant 3. a, Number of severe food preoccupation episodes per month after surgery (excluding month 1 after surgery because of a potential implantation effect27; month 4 had no episode). The green block denotes months 2–4. b, Participant 3 (left ventral NAc): spectrograms from magnet swipes for the control (left) and severe food preoccupation (right) conditions during the biomarker discovery phase (months 2–7). These spectrograms show power values per frequency from 1 to 10 Hz when the participant was relaxing (control; n = 33) or when the participant was in a severe food preoccupation state (n = 10). Each column corresponds to one magnet swipe episode, which is a participant-triggered iEEG recording (90 or 180 s). The red dashed line denotes the end of month 4 and the beginning of month 5 (see the green and pink bars above each spectrogram). For the results from the right ventral NAc, see Supplementary Fig. 5. Note that the apparent similarity in the number of severe food preoccupation episodes across months 2–4 versus months 5–7 arises from technical limitations (for example, device storage or trigger failure). Data reflect the number of available electrophysiological recordings. During months 2–4, the reported number of severe food preoccupation episodes was five but only four iEEG data were available, as shown on the right (under the green bar). Likewise, during months 5–7, the reported number was 11 but only six iEEG recordings were collected, as shown on the right (under the pink bar). c,d, Participant 3 (ventral NAc): power spectrum (mean ± s.e.m.) (c) and delta–theta band (≤7 Hz) power (d) when the participant was relaxing (control, blue) or in a severe food preoccupation state (pink) during months 2–4. c, The bottom black line shows statistically significant differences in power values between the control and severe food preoccupation (two-sided permutation testing (P < 0.05) conditions with cluster correction). There was no significant difference except at 7.2–8.8 Hz where the power value from severe food preoccupation was lower than the control. d, The center line of the box indicates the median; the bottom and top edges of the box indicate the 25th and 75th percentiles, respectively. The individual points outside the whiskers are considered as outliers. The top black line with a single asterisk shows statistically significant differences between two conditions after two-sided permutation testing (*P < 0.05). During months 2–4, there was also a 7% decrease in body weight relative to the baseline before surgery (138–128 kg; Supplementary Fig. 6). e,f, Power spectrum (mean ± s.e.m.) (e) and delta–theta band (≤7 Hz) power (f) from months 5–7, formatted as in c,d. c–f, For more information, see Supplementary Table 3.
Fig. 2 Association of increased delta–theta power in the ventral NAc with severe food preoccupation in participant 3. a, Number of severe food preoccupation episodes per month after surgery (excluding month 1 after surgery because of a potential implantation effect27; month 4 had no episode). The green block denotes months 2–4. b, Participant 3 (left ventral NAc): spectrograms from magnet swipes for the control (left) and severe food preoccupation (right) conditions during the biomarker discovery phase (months 2–7). These spectrograms show power values per frequency from 1 to 10 Hz when the participant was relaxing (control; n = 33) or when the participant was in a severe food preoccupation state (n = 10). Each column corresponds to one magnet swipe episode, which is a participant-triggered iEEG recording (90 or 180 s). The red dashed line denotes the end of month 4 and the beginning of month 5 (see the green and pink bars above each spectrogram). For the results from the right ventral NAc, see Supplementary Fig. 5. Note that the apparent similarity in the number of severe food preoccupation episodes across months 2–4 versus months 5–7 arises from technical limitations (for example, device storage or trigger failure). Data reflect the number of available electrophysiological recordings. During months 2–4, the reported number of severe food preoccupation episodes was five but only four iEEG data were available, as shown on the right (under the green bar). Likewise, during months 5–7, the reported number was 11 but only six iEEG recordings were collected, as shown on the right (under the pink bar). c,d, Participant 3 (ventral NAc): power spectrum (mean ± s.e.m.) (c) and delta–theta band (≤7 Hz) power (d) when the participant was relaxing (control, blue) or in a severe food preoccupation state (pink) during months 2–4. c, The bottom black line shows statistically significant differences in power values between the control and severe food preoccupation (two-sided permutation testing (P < 0.05) conditions with cluster correction). There was no significant difference except at 7.2–8.8 Hz where the power value from severe food preoccupation was lower than the control. d, The center line of the box indicates the median; the bottom and top edges of the box indicate the 25th and 75th percentiles, respectively. The individual points outside the whiskers are considered as outliers. The top black line with a single asterisk shows statistically significant differences between two conditions after two-sided permutation testing (*P < 0.05). During months 2–4, there was also a 7% decrease in body weight relative to the baseline before surgery (138–128 kg; Supplementary Fig. 6). e,f, Power spectrum (mean ± s.e.m.) (e) and delta–theta band (≤7 Hz) power (f) from months 5–7, formatted as in c,d. c–f, For more information, see Supplementary Table 3.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 36 · Cited by 10

Metadata

Authors
Choi, W., Nho, Y.-H., Qiu, L., Chang, A., Campos, G., Seilheimer, R. L., Wilent, W. B., Bakalov, D., Firdous, N., Kerr, M., Joshi, D., Maze, G., Topalovic, U., Batista, D., Suthana, N., Amaro, A., Hayes, M. R., Cajigas, I., Cristancho, M., Allison, K. C., Pesaran, B., Scangos, K. W., Gold, J. I., Wadden, T. A., & Halpern, C. H.
Affiliations
  • University of Pennsylvania (US)
  • University of Utah (US)
  • Duke University (US)
  • University of California, Los Angeles (US)
  • Philadelphia VA Medical Center (US)
Corresponding author
Halpern, Casey H.
Venue
Nature Medicine
Published
2025-11-17
Volume
31
Issue
12
Pages
4038-4043
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W4416283109
Cited by
10
References
36
Citations by year
2026: 9 · 2025: 1
FWCI
11.77
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Medicine (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
Funders
U.S. Department of Health & Human Services | National Institutes of Health (7UH3NS103446-03, 1R01MH124760-01A1 CHH)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
Keywords
tirzepatide, food preoccupation, obesity, nucleus accumbens, delta and theta oscillations, brain electrophysiology, incretin-based therapy, weight loss
MeSH terms
Tirzepatide, Brain, Feeding Behavior, Female, Humans, Middle Aged, Nucleus Accumbens, Obesity, Glucagon-Like Peptide 1, Incretins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide. https://app.cochat.ai/papers/10.1038/s41591-025-04035-5
The paper
Choi, W., Nho, Y.-H., Qiu, L., Chang, A., Campos, G., Seilheimer, R. L., Wilent, W. B., Bakalov, D., Firdous, N., Kerr, M., Joshi, D., Maze, G., Topalovic, U., Batista, D., Suthana, N., Amaro, A., Hayes, M. R., Cajigas, I., Cristancho, M., . . . Halpern, C. H. (2025). Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide. Nature Medicine. https://doi.org/10.1038/s41591-025-04035-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.